Bilateral transcranial magnetic stimulation of the supplementary motor area in children with Tourette syndrome.


Journal

Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761

Informations de publication

Date de publication:
07 2021
Historique:
accepted: 05 01 2021
pubmed: 27 2 2021
medline: 5 10 2021
entrez: 26 2 2021
Statut: ppublish

Résumé

To explore the feasibility and possible effects of low-frequency repetitive transcranial magnetic stimulation (rTMS) delivered to the supplementary motor area (SMA) on tic severity and motor system neurophysiology in children with Tourette syndrome. Ten children with Tourette syndrome (eight males, two females; 9-15y) participated in this open-label, phase 1 clinical trial. Treatment consisted of 1800 low-frequency (1Hz) neuronavigated robotic rTMS (100% resting motor threshold) to the SMA, bilaterally for 15 sessions. The primary outcome was a change in Yale Global Tic Severity Scale (YGTSS) total score from baseline to posttreatment. Secondary outcome measures included changes in magnetic resonance spectroscopy metabolite concentrations, TMS neurophysiology measures, TMS motor maps, and clinical assessments (anxiety, depression) from baseline to the end of treatment. The YGTSS score decreased from baseline after treatment (p<0.001; Cohen's d=2.9). All procedures were well-tolerated. Robot-driven, neuronavigated bilateral rTMS of the SMA is feasible in children with Tourette syndrome and appears to reduce tic severity. What this paper adds Repetitive transcranial magnetic stimulation (rTMS) is feasible to use in children with Tourette syndrome. rTMS is tolerated by children with Tourette syndrome. Precise targeting of the supplementary motor area using functional magnetic resonance imaging is also feasible in these children.

Identifiants

pubmed: 33634500
doi: 10.1111/dmcn.14828
doi:

Types de publication

Clinical Trial, Phase I Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

808-815

Subventions

Organisme : CIHR
Pays : Canada

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 Mac Keith Press.

Références

Pringsheim T, Holler-Managan Y, Okun MS, et al. Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019; 92: 907-15.
Kwon HJ, Lim WS, Lim MH, et al. 1-Hz low frequency repetitive transcranial magnetic stimulation in children with Tourette's syndrome. Neurosci Lett 2011; 492: 1-4.
Le K, Liu L, Sun M, Hu L, Xiao N. Transcranial magnetic stimulation at 1 Hertz improves clinical symptoms in children with Tourette syndrome for at least 6 months. J Clin Neurosci 2013; 20: 257-62.
Mantovani A, Lisanby SH, Pieraccini F, Ulivelli M, Castrogiovanni P, Rossi S. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). Int J Neuropsychopharmacol 2006; 9: 95-100.
Voon V, Derbyshire K, Ruck C, et al. Disorders of compulsivity: a common bias towards learning habits. Mol Psychiatry 2015; 20: 345-52.
Delorme C, Salvador A, Valabregue R, et al. Enhanced habit formation in Gilles de la Tourette syndrome. Brain 2016; 139: 605-15.
Jackson GM, Draper A, Dyke K, Pepes SE, Jackson SR. Inhibition, disinhibition, and the control of action in Tourette syndrome. Trends Cogn Sci 2015; 19: 655-65.
Draper A, Stephenson MC, Jackson GM, et al. Increased GABA contributes to enhanced control over motor excitability in Tourette syndrome. Curr Biol 2014; 24: 2343-7.
Mantovani A, Leckman JF, Grantz H, King RA, Sporn AL, Lisanby SH. Repetitive transcranial magnetic stimulation of the supplementary motor area in the treatment of Tourette Syndrome: report of two cases. Clin Neurophysiol 2007; 118: 2314-5.
Bloch Y, Arad S, Levkovitz Y. Deep TMS add-on treatment for intractable Tourette syndrome: a feasibility study. World J Biol Psychiatry 2016; 17: 557-61.
Landeros-Weisenberger A, Mantovani A, Motlagh MG, et al. Randomized sham controlled double-blind trial of repetitive transcranial magnetic stimulation for adults with severe Tourette syndrome. Brain Stimul 2015; 8: 574-81.
Singh S, Kumar S, Kumar N, Verma R. Low-frequency repetitive transcranial magnetic stimulation for treatment of Tourette syndrome: a naturalistic study with 3 months of follow-up. Indian J Psychol Med 2018; 40: 482-6.
Krieg SM, Sabih J, Bulubasova L, et al. Preoperative motor mapping by navigated transcranial magnetic brain stimulation improves outcome for motor eloquent lesions. Neuro Oncol 2014; 16: 1274-82.
Di Lazzaro V, Rothwell JC. Corticospinal activity evoked and modulated by non-invasive stimulation of the intact human motor cortex. J Physiol 2014; 592: 4115-28.
Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989; 28: 566-73.
Garvey MA, Kaczynski KJ, Becker DA, Bartko JJ. Subjective reactions of children to single-pulse transcranial magnetic stimulation. J Child Neurol 2001; 16: 891-4.
Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-9.
Edden RA, Puts NA, Harris AD, Barker PB, Evans CJ. Gannet: a batch-processing tool for the quantitative analysis of gamma-aminobutyric acid-edited MR spectroscopy spectra. J Magn Reson Imaging 2014; 40: 1445-52.
Sale MV, Reid LB, Cocchi L, Pagnozzi AM, Rose SE, Mattingley JB. Brain changes following four weeks of unimanual motor training: evidence from behavior, neural stimulation, cortical thickness, and functional MRI. Hum Brain Mapp 2017; 38: 4773-87.
Zewdie E, Kirton A. TMS Basics: Single and Paired Pulse Neurophysiology. Amsterdam: Elsevier, 2016: 3-22.
Grab JG, Zewdie E, Carlson HL, et al. Robotic TMS mapping of motor cortex in the developing brain. J Neurosci Methods 2018; 309: 41-54.
Wu SW, Maloney T, Gilbert DL, et al. Functional MRI-navigated repetitive transcranial magnetic stimulation over supplementary motor area in chronic tic disorders. Brain Stimul 2014; 7: 212-8.
Orth M, Kirby R, Richardson MP, et al. Subthreshold rTMS over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome. Clin Neurophysiol 2005; 116: 764-8.
Orth M, Rothwell JC. Motor cortex excitability and comorbidity in Gilles de la Tourette syndrome. J Neurol Neurosurg Psychiatry 2009; 80: 29-34.
Paulus W, Classen J, Cohen LG, et al. State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimul 2008; 1: 151-63.
Sigurdsson HP, Jackson SR, Kim S, Dyke K, Jackson GM. A feasibility study for somatomotor cortical mapping in Tourette syndrome using neuronavigated transcranial magnetic stimulation. Cortex 2020; 129: 175-87.

Auteurs

Cynthia K Kahl (CK)

Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Adam Kirton (A)

Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Tamara Pringsheim (T)

Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Paul E Croarkin (PE)

Departments of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

Ephrem Zewdie (E)

Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Rose Swansburg (R)

Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

James Wrightson (J)

Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Lisa Marie Langevin (LM)

Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Strategic Clinical Network for Neuroscience, Vision, and Rehabilitation, Calgary, Alberta, Canada.

Frank P Macmaster (FP)

Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Strategic Clinical Network for Addictions and Mental Health, Calgary, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH